elluminate® Clinical Data Platform from eClinical Solutions Selected by Celsius Therapeutics to Speed Insights & Value of Clinical Data
Summary
Celsius Therapeutics is developing a new model of target and drug discovery that leverages a systematic approach to single-cell sequencing. Celsius is using the elluminate platform and Mapper application to: • Aggregate clinical metadata within and across studies, without the time and costs associated with relying on programmers to aggregate and standardize data • Integrate numerous different and disparate data sources for rapid clinical and translational insights “We are inspired by the work of clients like Celsius Therapeutics who are taking innovative approaches to the discovery of new medicines,” said Raj Indupuri, eClinical Solutions Co-Founder and CEO. “The elluminate platform and Mapper application are designed to help life sciences companies like Celsius unlock the value of their data faster, replacing manual processes with automated insights.” About eClinical Solutions LLC eClinical Solutions is a leading provider of cloud based enterprise software and software-driven clinical data services. The elluminate® platform provides life sciences companies with greater control of their clinical trial data. About Celsius Therapeutics Celsius Therapeutics is charting a new course of target and drug discovery by applying a systematic approach to single-cell sequencing of patient tissue, combining massive datasets, complex algorithms, and machine learning to discover first-in-class precision therapies with a transformative impact on the lives of patients with autoimmune diseases and cancer.